← Back to feedRead original →
VERIFIEDET Stocks·positive
JM Financial sees up to 28% upside in Dr Reddy’s and Aurobindo Pharma. Should you buy?
AI Summary
- ·JM Financial maintained Buy ratings on Dr Reddy’s Laboratories and Aurobindo Pharma.
- ·The brokerage anticipates up to 28% upside for both companies in the next 12 months.
- ·JM Financial cited stronger earnings growth, business diversification, and new product launches as key drivers.